M. Świderska

Publications48
h-index9
Citations313
Highly Influential Citations13
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Maciejczyk
  • 70 Publications, 993 Citations
  • A. Zalewska
  • 173 Publications, 2,176 Citations
  • J. Jaroszewicz
  • 222 Publications, 2,832 Citations
  • R. Flisiak
  • 414 Publications, 11,768 Citations
  • Publications
  • Influence
The diagnostics of colorectal cancer
Colorectal cancer (CRC) is one of the most frequent human malignant neoplasms. CRC has an estimated incidence of more than 1,000,000 new cases annually worldwide. Approximately one out of three… Expand
  • 54
  • 3
  • PDF
Effect of psoriasis activity on serum adiponectin and leptin levels
Introduction Psoriasis is an inflammatory and chronic skin disease associated with obesity, cardiovascular diseases, diabetes and metabolic syndrome. Adipokines, as bioactive substances secreted from… Expand
  • 32
  • 3
  • PDF
Serum YKL-40 as a potential biomarker of inflammation in psoriasis
Abstract Objective: YKL-40 is an inflammatory glycoprotein associated with atherosclerosis, cardiovascular disease, diabetes or metabolic syndrome which are common comorbidities in psoriasis. The aim… Expand
  • 11
  • 2
Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer.
PURPOSE The role of lipids in carcinogenesis through induction of abnormal cell lines in the human body is currently undisputable. Based on the literature, bioactive sphingolipids play an essential… Expand
  • 23
  • 1
Serum adiponectin and leptin levels in psoriatic patients according to topical treatment
Abstract Objectives: Psoriasis has been considered as a systemic disease associated with obesity, cardiovascular diseases and metabolic syndrome. Adipokines have influence on many metabolic… Expand
  • 21
  • 1
The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a chronic progressive liver disease, coupled with metabolic syndrome, which may progress to non-alcoholic steatohepatitis (NASH). Diabetes, obesity,… Expand
  • 10
  • 1
  • PDF
Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients
Abstract Still little is known about the redox abnormalities in patients with non-alcoholic fatty liver disease (NAFLD). The purpose of the study was to find the relationship between enzymatic and… Expand
  • 22
  • 1
Serum Concentrations of Th17-Associated Interleukins and Autoimmune Phenomena are Associated with the Degree of Liver Damage in Alcoholic Liver Disease.
BACKGROUND AND AIMS Recent reports suggest an involvement of Th17 responses in inflammatory and autoimmune reactions in alcoholic liver disease (ALD). Our study aimed to assess serum levels of… Expand
  • 6
  • 1
Serum cytochrome c and m30‐neoepitope of cytokeratin‐18 in chronic hepatitis C
Cytochrome c (CYC) and M30‐neoepitope of cytokeratin‐18 (M30‐CK18) are involved at different levels in apoptotic pathways. We aimed to evaluate an association between serum CYC, M30‐CK18 and disease… Expand
  • 28
Serum irisin levels in patients with psoriasis
Abstract Background: Irisin has been proposed to regulate metabolic diseases such as obesity, diabetes or metabolic syndrome which are common comorbidities in psoriasis. Objectives: The aim of this… Expand
  • 9